We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDIT icon
401
Editas Medicine
EDIT
$445M
$678K 0.01%
82,369
+18,319
+29% +$160K
CRL icon
402
Charles River Laboratories
CRL
$12.7B
$675K 0.01%
3,211
+158
+5% +$31.4K
PRAX icon
403
Praxis Precision Medicines
PRAX
$10.3B
$671K 0.01%
38,903
+5,086
+15% +$77.9K
CNTB
404
Connect Biopharma Holdings
CNTB
$138M
$670K 0.01%
603,900
+29,752
+5% +$33.4K
MRK icon
405
Merck
MRK
$317B
$668K 0.01%
5,790
-12,074
-68% -$1.37M
AGNC icon
406
AGNC Investment
AGNC
$12.6B
$662K 0.01%
65,381
-81,571
-56% -$793K
H icon
407
PUT
Hyatt Hotels
H
$16.9B
$661K 0.01%
237,000
+21,500
+10% +$2.43M
W icon
408
Wayfair
W
$14.3B
$650K 0.01%
+10,000
New +$421K
GEHC icon
409
GE HealthCare
GEHC
$31.8B
$637K 0.01%
7,835
-565
-7% -$45.1K
AKTS
410
DELISTED
Akoustis Technologies Inc
AKTS
$636K 0.01%
200,000
+100,000
+100% +$307K
MIRM icon
411
Mirum Pharmaceuticals
MIRM
$5.74B
$621K 0.01%
+24,000
New +$638K
GTLS
412
DELISTED
Chart Industries
GTLS
$616K 0.01%
+3,856
New +$493K
WIX icon
413
WIX.com
WIX
$2.55B
$587K 0.01%
+7,500
New +$617K
KLRS
414
Kalaris Therapeutics
KLRS
$99.7M
$578K 0.01%
+7,391
New +$703K
TRIP icon
415
TripAdvisor
TRIP
$1.22B
$577K 0.01%
35,000
+10,000
+40% +$169K
LGIH icon
416
LGI Homes
LGIH
$1.38B
$577K 0.01%
+4,275
New +$513K
NVNO
417
enVVeno Medical
NVNO
$6.78M
$575K 0.01%
5,338
+263
+5% +$34.2K
KBR icon
418
KBR
KBR
$4.74B
$572K 0.01%
+8,792
New +$524K
DOC icon
419
Healthpeak Properties
DOC
$14.5B
$547K 0.01%
+27,200
New +$565K
ELAN icon
420
Elanco Animal Health
ELAN
$12.1B
$545K 0.01%
54,176
+12,176
+29% +$113K
AURA icon
421
Aura Biosciences
AURA
$799M
$543K 0.01%
+44,000
New +$470K
SLN
422
Silence Therapeutics
SLN
$554M
$541K 0.01%
98,326
+2,943
+3% +$17.7K
PTON icon
423
PUT
Peloton Interactive
PTON
$2.38B
$532K 0.01%
300,000
-185,000
-38% -$1.57M
LCA
424
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$515K 0.01%
50,644
-1,141
-2% -$11.5K
RETA
425
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$510K 0.01%
5,000
-250
-5% -$23.7K
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.